Dr. Agarwal's Health Care Ltd. (IN:AGARWALEYE)
:AGARWALEYE
AGARWALEYE Stock Chart & Stats
₹500.00
--
Market closed
₹500.00
--
Day’s Range― - ―
52-Week Range₹327.40 - ₹567.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)13.83K
Market Cap
₹137.89B
Enterprise Value₹146.06B
Total Cash (Recent Filing)₹3.97B
Total Debt (Recent Filing)₹9.83B
Price to Earnings (P/E)118.8
Beta0.59
Next Earnings
Jun 03, 2026EPS Estimate
1.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.10
Shares Outstanding316,807,500
10 Day Avg. Volume7,500
30 Day Avg. Volume13,832
Financial Highlights & Ratios
PEG Ratio43.43
Price to Book (P/B)7.19
Price to Sales (P/S)7.85
P/FCF Ratio589.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.6
Revenue Forecast (FY)₹24.77B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue & Profit GrowthConsistent revenue and profit growth strengthens scale and internal funding capacity, enabling reinvestment in centers, talent, and technology. Over the next 2–6 months this durable top-line momentum supports service expansion, negotiating leverage with suppliers/insurers, and resiliency through demand swings.
Strong Operating Cash GenerationReliable operating cash flow and growing free cash flow provide sustainable funding for capex, working capital and debt servicing without frequent equity raises. This cash generation underpins steady center investments and creates optionality for strategic moves across a multi-month horizon.
Improving Operating MarginsHealthy gross margins and rising EBIT/EBITDA margins indicate structural cost control and operational leverage as volumes scale. Sustained margin improvement supports reinvestment, competitive pricing flexibility, and a buffer against input cost swings over the medium term.
Bears Say
Moderate LeverageA moderately high debt-to-equity ratio raises financial risk by increasing interest burden and refinancing exposure. Over 2–6 months elevated leverage can constrain cash flow flexibility, limit strategic choices (M&A, capex) and increase vulnerability if patient volumes or margins temporarily weaken.
Net Profit Margin VolatilityVolatile net margins reflect sensitivity to expense swings, financing costs or one-time items and reduce earnings predictability. This complicates budgeting and capital allocation, meaning management may need to retain cushions that slow returns or cautious expansion over the medium term.
Growth Dependent On Network ExpansionReliance on opening and ramping new centers makes growth capital intensive and execution-dependent. Over several months misexecution, slower patient ramp or higher capex per site can compress returns and delay revenue realization, adding operational risk to the expansion-led growth model.
Dr. Agarwal's Health Care Ltd. News
AGARWALEYE FAQ
What was Dr. Agarwal's Health Care Ltd.’s price range in the past 12 months?
Dr. Agarwal's Health Care Ltd. lowest stock price was ₹327.40 and its highest was ₹567.80 in the past 12 months.
What is Dr. Agarwal's Health Care Ltd.’s market cap?
Dr. Agarwal's Health Care Ltd.’s market cap is ₹137.89B.
When is Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date?
Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 51 days.
How were Dr. Agarwal's Health Care Ltd.’s earnings last quarter?
Dr. Agarwal's Health Care Ltd. released its earnings results on Feb 13, 2026. The company reported ₹1.1 earnings per share for the quarter, beating the consensus estimate of ₹1 by ₹0.1.
Is Dr. Agarwal's Health Care Ltd. overvalued?
According to Wall Street analysts Dr. Agarwal's Health Care Ltd.’s price is currently Overvalued.
Does Dr. Agarwal's Health Care Ltd. pay dividends?
Dr. Agarwal's Health Care Ltd. does not currently pay dividends.
What is Dr. Agarwal's Health Care Ltd.’s EPS estimate?
Dr. Agarwal's Health Care Ltd.’s EPS estimate is 1.07.
How many shares outstanding does Dr. Agarwal's Health Care Ltd. have?
Dr. Agarwal's Health Care Ltd. has 316,807,500 shares outstanding.
What happened to Dr. Agarwal's Health Care Ltd.’s price movement after its last earnings report?
Dr. Agarwal's Health Care Ltd. reported an EPS of ₹1.1 in its last earnings report, beating expectations of ₹1. Following the earnings report the stock price went down -0.84%.
Which hedge fund is a major shareholder of Dr. Agarwal's Health Care Ltd.?
Currently, no hedge funds are holding shares in IN:AGARWALEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dr. Agarwal's Health Care Ltd.
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Jupiter Life Line Hospitals Ltd.
―
Marksans Pharma Limited
―
Metropolis Healthcare Ltd.
―
Rainbow Childrens Medicare Limited
―